Related Experiment Videos
Recurrent renal disease after renal transplantation
1Clinical Science Labs, Guy's Hospital, London, UK.
Current Opinion in Nephrology and Hypertension
|November 1, 1994
Summary
Kidney transplant recipients face recurrent disease risks, particularly those with specific conditions like type I hyperoxaluria. While not always causing graft loss, recurrence impacts donor choices and long-term graft survival.
Area of Science:
- Nephrology
- Transplantation Immunology
- Renal Medicine
Background:
- Recurrent kidney disease post-transplantation is a significant clinical concern.
- Specific conditions like type I hyperoxaluria and focal segmental glomerulosclerosis present unique challenges.
- The incidence and impact of recurrent diseases on graft survival require ongoing investigation.
Purpose of the Study:
- To review the impact of recurrent diseases on kidney allograft survival.
- To discuss the implications for donor selection and long-term graft outcomes.
- To highlight recent debates regarding immunosuppression and specific recurrent nephropathies.
Main Methods:
- Literature review of recurrent kidney diseases after transplantation.
- Analysis of clinical outcomes in patients with various underlying renal failures.
- Discussion of current controversies in transplantation management.
Main Results:
- Recurrent disease is a concern but does not always lead to graft loss.
- Certain conditions, including type I hyperoxaluria and focal segmental glomerulosclerosis, are associated with higher risks.
- IgA nephropathy, membranous nephropathy, and Finnish congenital nephrotic syndrome have specific recurrence patterns and outcomes.
Conclusions:
- Recurrent kidney diseases pose a serious threat to allograft survival in specific patient populations.
- Understanding recurrence patterns is crucial for patient management and donor selection.
- Further research is needed to mitigate the impact of recurrent diseases on long-term graft function.